MARKET

INZY

INZY

Inozyme Pharma, Inc.
NASDAQ
1.000
0.000
0.03%
After Hours: 1.020 +0.02 +2.00% 17:58 03/14 EDT
OPEN
1.020
PREV CLOSE
0.9997
HIGH
1.030
LOW
0.9801
VOLUME
657.01K
TURNOVER
--
52 WEEK HIGH
7.80
52 WEEK LOW
0.9800
MARKET CAP
64.24M
P/E (TTM)
-0.6157
1D
5D
1M
3M
1Y
5Y
1D
Inozyme Pharma Is Maintained at Outperform by Raymond James
Dow Jones · 3d ago
Inozyme Pharma Price Target Cut to $12.00/Share From $24.00 by Raymond James
Dow Jones · 3d ago
Raymond James Maintains Outperform on Inozyme Pharma, Lowers Price Target to $12
Benzinga · 3d ago
INOZYME PHARMA INC <INZY.O>: RAYMOND JAMES CUTS TARGET PRICE TO $12 FROM $24
Reuters · 4d ago
U.S. RESEARCH ROUNDUP-AbbVie, Dick's Sporting, Oracle
Reuters · 4d ago
Inozyme Pharma Price Target Cut to $23.00/Share From $30.00 by Piper Sandler
Dow Jones · 4d ago
Inozyme Pharma Is Maintained at Overweight by Piper Sandler
Dow Jones · 4d ago
Piper Sandler Maintains Overweight on Inozyme Pharma, Lowers Price Target to $23
Benzinga · 4d ago
More
About INZY
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. The Company is focused on developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue and skeleton. The Company is also focused on developing a novel therapy to treat the rare genetic diseases of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) and ATP-Binding Cassette in the C6 family (ABCC6) Deficiencies. The Company’s lead product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to cleave extracellular adenosine triphosphate (ATP) to generate plasma pyrophosphate (PPi) and adenosine monophosphate (AMP), which can be processed to phosphate and adenosine. Its INZ-701 is in clinical development for the treatment of ENPP1 Deficiency, ABCC6 Deficiency and calciphylaxis.

Webull offers Inozyme Pharma Inc stock information, including NASDAQ: INZY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INZY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INZY stock methods without spending real money on the virtual paper trading platform.